If approved, Forxiga would become the first SGLT2 inhibitor indicated for heart failure with reduced ejection fraction in patients with and without type-2 diabetes... Oct 19
Glenmark received approval from ANDA for Sirolimus Tablets, a generic version of Rapamune Tablets... Oct 19
Zydus Cadila has received tentative approval to market 11 mg Tofacitinib Extended-Release Tablets... Oct 19
Trixeo Aerosphere recommended for approval in the EU by CHMP for the maintenance treatment of COPD... Oct 19
-Advertisements-